Disclosure Of First-Time Adoption [Text Block]

Xspray Pharma - Filing #702829

Concept	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Disclosure of first-time adoption [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity	243 387 SEK	976,000 SEK	813 483 SEK	—	591 752 SEK	—	20 680 SEK	—	—	—	146 689 SEK	—	709 407 SEK	18 893 SEK	—	976,000 SEK	—	—	582 587 SEK	—	976,000 SEK	450 266 SEK	373 715 SEK	94 279 SEK	16 752 SEK
Comprehensive income	—	—	—	- SEK	—	- SEK	—	- SEK	96 698 SEK	96 698 SEK	—	52 410 SEK	—	—	52 410 SEK	—	- SEK	- SEK	—	- SEK	—	—	—	—	—
Profit (loss)	—	—	—	- SEK	—	- SEK	—	- SEK	96 698 SEK	96 698 SEK	—	52 410 SEK	—	—	52 410 SEK	—	- SEK	- SEK	—	- SEK	—	—	—	—	—